BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8001 related articles for article (PubMed ID: 11436353)

  • 21. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M; Ryuke Y; Yoshida J
    Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HSV-TK/IL-2 gene therapy for glioblastoma multiforme.
    Barzon L; Pacenti M; Franchin E; Colombo F; Palù G
    Methods Mol Biol; 2009; 542():529-49. PubMed ID: 19565921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O; Síma P; Kunke D
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes.
    Walling HW; Swarthout JT; Culver KW
    Cancer Gene Ther; 2000 Feb; 7(2):187-96. PubMed ID: 10770626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
    Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
    Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antitumor gene therapy using suicide genes].
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Medicina (B Aires); 1998; 58(2):185-8. PubMed ID: 9706253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene.
    Vandier D; Rixe O; Brenner M; Gouyette A; Besnard F
    Cancer Res; 1998 Oct; 58(20):4577-80. PubMed ID: 9788604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene].
    Quillien V; Heresbach Le Berre N; Dufour T; Denais A; Guegan Y; Ferry N; Bloin V
    Bull Cancer; 1997 Nov; 84(11):1047-52. PubMed ID: 9536986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging.
    Maron A; Gustin T; Le Roux A; Mottet I; Dedieu JF; Brion JP; Demeure R; Perricaudet M; Octave JN
    Gene Ther; 1996 Apr; 3(4):315-22. PubMed ID: 8732163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
    Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
    Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 401.